Immunotherapy

Thousand Oaks, California, U.S., September 14, 2026 Amgen announced that the U.S. Food and Drug Administration (FDA) has approved...

Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...

Shanghai, China, September 10, 2026 Solstice Oncology, a partner of Harbour BioMed, has announced a $225 million Series A...

Thousand Oaks, California, USA, September 8, 2026 Amgen and AstraZeneca have announced positive results from the Phase 3 DeLLphi-305...

SEATTLE, Washington and CAMBRIDGE, Massachusetts — September 8, 2026 BrainChild Bio, Inc. announced the initiation of the pivotal Phase...

Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) injection...

Mumbai, India and Warren, New Jersey, USA, September 3, 2026 Cipla Limited, through its wholly owned subsidiary InvaGen Pharmaceuticals...

OCALA, Fla., Sept. 2, 2026 AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharmaceutical company developing Ampligen® (rintatolimod), announced that...

MIRAMAR, Fla., Sept. 2, 2026 HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for autoimmune...

WATERTOWN, Mass., September 2, 2026 Treeline Biosciences, Inc. announced a clinical trial collaboration and supply agreement with Roche to...